908 Devices Valuation Multiples

908 Devices Overview

About 908 Devices

908 Devices Inc manufactures medical devices. It has developed a suite of purpose-built handheld and desktop mass spectrometry, or Mass Spec, devices for the point-of-need. Mass Spec devices are used at the point-of-need to interrogate unknown and invisible materials and provide quick, actionable answers to directly address some of the critical problems in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company geographically derives maximum revenue from United States, and also has its presence in Europe, Middle East and Africa, Americas and Other and Asia Pacific.

Founded

2012

HQ

Employees

71

Website

908devices.com

Sectors

Medical DevicesLaboratory ServicesDeepTechHealthTech

Financials (LTM)

Revenue: $58M

EBITDA: ($8M)

EV

$137M

Valuation Multiples

Multiples.vc

Start free trial

908 Devices Financials

908 Devices reported last 12-month revenue of $58M and negative EBITDA of ($8M).

In the same LTM period, 908 Devices generated $38M in gross profit, ($8M) in EBITDA losses, and had net loss of ($29M).

908 Devices P&L

In the most recent fiscal year, 908 Devices reported revenue of $56M and EBITDA of ($10M).

908 Devices expects next 12-month revenue of XXX and NTM EBITDA of XXX

908 Devices Stock Performance

908 Devices has current market cap of $244M, and enterprise value of $137M.

908 Devices' stock price is $6.75.

908 Devices Valuation Multiples

908 Devices trades at 2.3x EV/Revenue multiple, and (16.2x) EV/EBITDA.

908 Devices Financial Valuation Multiples

As of March 24, 2026, 908 Devices has market cap of $244M and EV of $137M.

Equity research analysts estimate 908 Devices' 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

908 Devices has a P/E ratio of (8.4x).

908 Devices Margins & Growth Rates

908 Devices' revenue in the last 12 month grew by 18%.

908 Devices' revenue per employee in the last FY averaged $0.8M.

908 Devices' rule of 40 is 3% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

908 Devices' rule of X is 30% (created by Bessemer, rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

908 Devices Public Comps

See public comps and valuation multiples for other Medical Devices and Laboratory Services comps.

908 Devices M&A Activity

908 Devices acquired XXX companies to date.

Last acquisition by 908 Devices was on XXXXXXXX, XXXXX. 908 Devices acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).

908 Devices Investment Activity

908 Devices invested in XXX companies to date.

908 Devices made its latest investment on XXXXXXXX, XXXXX. 908 Devices invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).